The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes

Diagn Pathol. 2011 May 11:6:40. doi: 10.1186/1746-1596-6-40.

Abstract

Background: Type 2 diabetes is mainly caused by insulin resistance. The carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is an important candidate for causing insulin resistance.

Methods: The CEACAM1 expression was evaluated immunohistochemically in the liver tissues of 99 severely obese or non-obese subjects with or without diabetes. The CEACAM1 expression was classified into two categories: a normal expression or a decreased expression.

Results: The CEACAM1 expression was markedly decreased in the hepatocytes with macrovesicular steatosis. A decreased CEACAM1 expression was noted in 29 (29%) of 99 cases. The incidence of a decreased CEACAM1 expression was significantly higher in high grade fatty liver as well as severe obesity with or without diabetes (p < 0.05). The incidence of a decreased CEACAM1 expression was not different between the diabetic and non-diabetic groups.

Conclusions: This data supports that a decreased CEACAM1 expression is related to obesity and a fatty liver.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD / metabolism*
  • Biomarkers / metabolism
  • Biopsy
  • Cell Adhesion Molecules / metabolism*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / pathology
  • Fatty Liver / complications
  • Fatty Liver / metabolism*
  • Fatty Liver / pathology
  • Hepatocytes / metabolism
  • Hepatocytes / pathology
  • Humans
  • Middle Aged
  • Obesity, Morbid / complications
  • Obesity, Morbid / metabolism*
  • Obesity, Morbid / pathology

Substances

  • Antigens, CD
  • Biomarkers
  • CD66 antigens
  • Cell Adhesion Molecules